Share of sales outside Denmark of Novo Nordisk 2008-2018

This statistic shows the share of sales outside of Denmark of Novo Nordisk from 2007 to 2017. Novo Nordisk is a Danish pharmaceutical company founded in 1923. The company's key product is diabetes medication, but does also produce pharmaceuticals for other use. The share of sales to outside Denmark was above 99 percent for the whole period. The highest shares of sales outside Denmark was in 2015, as well as in 2016, when the share was 99.7 percent. In 2017, 99.6 percent of the sales were generated outside of Denmark.

Share of sales outside Denmark of Novo Nordisk from 2008 to 2018

Share of sales
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2019

Region

Denmark

Survey time period

2008 to 2018

Supplementary notes

Some figures have been taken from previous publications.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.